Bank of America Has Lowered Expectations for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its target price lowered by Bank of America from $32.00 to $9.00 in a report released on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price target points to a potential upside of 243.51% from the company’s current […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its target price lowered by Bank of America from $32.00 to $9.00 in a report released on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price target points to a potential upside of 243.51% from the company’s current […]
